Published in Milbank Mem Fund Q Health Soc on January 01, 1984
Promoting rational prescribing: an international perspective. Br J Clin Pharmacol (1995) 2.88
Evaluating the capability of information technology to prevent adverse drug events: a computer simulation approach. J Am Med Inform Assoc (2002) 2.10
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene. Am J Public Health (1987) 1.29
Evaluation of medical audit. J Epidemiol Community Health (1994) 1.24
Quality of requests for serum digoxin concentrations: experience from an Australian regional health service. Br J Clin Pharmacol (2006) 0.86
Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study. BMC Health Serv Res (2006) 0.75
The use of sedative-hypnotic drugs in a university teaching hospital. CMAJ (1990) 0.75
Realities of drug use in society. Drug Saf (1990) 0.75
Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther (2002) 13.95
Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA (1990) 10.01
Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med (1983) 8.56
Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50
Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med (1982) 7.14
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol (2001) 7.04
Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med (1991) 5.94
Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care (1999) 4.96
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med (1987) 4.57
Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q (1989) 4.49
A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med (1992) 4.49
Incidence and preventability of adverse drug events in nursing homes. Am J Med (2000) 4.33
The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA (1992) 4.28
Physician motivations for nonscientific drug prescribing. Soc Sci Med (1989) 3.84
Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis (2006) 3.48
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ (2012) 3.44
Examining product risk in context. Market withdrawal of zomepirac as a case study. JAMA (1993) 3.42
Evaluating drugs after their approval for clinical use. N Engl J Med (1993) 3.19
Risk factors for adverse drug events among nursing home residents. Arch Intern Med (2001) 3.12
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA (2000) 3.03
Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med (1996) 2.92
Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med (2000) 2.62
Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med (1994) 2.62
Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA (2001) 2.55
Paradoxical relations of drug treatment with mortality in older persons. Epidemiology (2001) 2.52
Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics (2001) 2.41
Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health (1996) 2.33
Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics (2000) 2.31
Refilling and switching of antiepileptic drugs and seizure-related events. Clin Pharmacol Ther (2010) 2.31
Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med (1997) 2.30
A controlled trial of educational outreach to improve blood transfusion practice. JAMA (1993) 2.28
Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med (1993) 2.27
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens (1997) 2.21
Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med (2001) 2.13
Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. N Engl J Med (1984) 2.12
Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc (1997) 2.09
Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med (1997) 2.01
Aging and the anticoagulant response to warfarin therapy. Ann Intern Med (1992) 1.97
Treatment for glaucoma: adherence by the elderly. Am J Public Health (1993) 1.90
Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study. N Engl J Med (1989) 1.86
The ambiguous relation between aging and adverse drug reactions. Ann Intern Med (1991) 1.82
Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc (1999) 1.82
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry (2001) 1.80
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77
How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med (1997) 1.75
The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies. Health Policy Plan (1996) 1.74
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J (1999) 1.70
Zolpidem use and hip fractures in older people. J Am Geriatr Soc (2001) 1.68
Economic and policy analysis of university-based drug "detailing". Med Care (1986) 1.67
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med (1999) 1.64
Improving drug use in elderly patients: getting to the next level. JAMA (2001) 1.63
Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol (1989) 1.61
Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment. JAMA (1990) 1.61
Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (1995) 1.60
HMO formularies and care costs. Lancet (1996) 1.60
Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med (1988) 1.59
Psychoactive medication use in intermediate-care facility residents. JAMA (1988) 1.50
Predictors of uncontrolled hypertension in ambulatory patients. Hypertension (2001) 1.49
Reducing the use of H2-receptor antagonists in the long-term-care setting. J Am Geriatr Soc (1992) 1.48
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia (2005) 1.46
The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med (1997) 1.46
Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis (2001) 1.45
Blood donation by the elderly. Clinical and policy considerations. JAMA (1987) 1.45
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
The case for a medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health (2001) 1.43
A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. J Gen Intern Med (1995) 1.41
Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc (1990) 1.41
Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med (1994) 1.41
Late referral and modality choice in end-stage renal disease. Kidney Int (2001) 1.40
Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis (2007) 1.39
Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter? Health Aff (Millwood) (2001) 1.39
Behavior changes after notification of HIV infection. Am J Public Health (1991) 1.38
Quality assurance for drug prescribing. Qual Assur Health Care (1990) 1.38
Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med (2001) 1.33
Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol (1999) 1.32
Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting. J Am Geriatr Soc (2001) 1.31
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene. Am J Public Health (1987) 1.29
The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia (2004) 1.26
Increased antidepressant use in patients prescribed beta-blockers. JAMA (1986) 1.26
Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies. JAMA (1990) 1.25
Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA (1994) 1.24
Systemic effects of medications used to treat glaucoma. Ann Intern Med (1990) 1.24
Clinical decision-making in the evaluation and treatment of insomnia. Am J Med (1990) 1.24
The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines? Cancer (1998) 1.24
A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int (2006) 1.22
Physicians' knowledge of drug costs for the elderly. J Am Geriatr Soc (1994) 1.21
A new approach to reducing suboptimal drug use. JAMA (1983) 1.21
Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol (1997) 1.20
Consultation between cardiologists and generalists in the management of acute myocardial infarction: implications for quality of care. Arch Intern Med (1998) 1.17
Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant (2007) 1.16
Patterns of drug use in rheumatoid arthritis. J Rheumatol (2000) 1.16